In this episode of The Cole Memo, we mainly watch the live MAPS press conference that I was invited to, where leadership addressed the FDA’s newly released complete response letter rejecting MDMA assisted therapy for PTSD. You’ll hear their perspective on shifting standards, trial design disputes, and what this decision means for the future of psychedelic medicine.
To set the stage, I begin with a clip from Hamilton Morris on drug journalism and the FDA’s rejection of MDMA therapy, then we tune into the full press conference.
- Watch the episode on Youtube here
- Stream the episode on Soundcloud here
- Stream the episode on Spotify here
- Stream the episode on Apple Podcast here
- Stream the episode on X here
Links mentioned during show
- Interview with Hamilton Morris that I showed first can be viewed here
- FDA Releases MDMA Therapy Rejection Letter, MAPS Rick Doblin Responds
- Analysis article by Psychedelic Alpha on the published response letter from the FDA can be read here
- My podcast episode with Dr. Sam Banister can be viewed here
The Cole Memo 
Leave a comment